Evidence map›Paper›PMID 21525871›Full record

ArticleMolecular systems biology2011

Origin of bistability underlying mammalian cell cycle entry.

Guang Yao, Cheemeng Tan, Mike West, Joseph R Nevins, Lingchong You

Abstract read
In one paragraph

Article in Molecular systems biology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 68 papers.

0numbers the graph read from it
0cells of the map it votes in
68citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

68 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Systems Biology of the Cancer Cell.Annual review of biomedical engineering · 2025
    Review
  6. Article
  7. Review
  8. Article
  9. The art of modeling gene regulatory circuits.NPJ systems biology and applications · 2024
    Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

8 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Guang YaoDepartment of Molecular & Cellular Biology, University of Arizona, Tucson, AZ 85721, USA. guangyao@arizona.edu
Cheemeng Tan
Mike West
Joseph R Nevins
Lingchong You

Funding

Project 6P50GM081883 · NIGMS · DUKE UNIVERSITY · PI BENFEY, PHILIP N · 2007 to 2012
$14.9M
NIGMS NIH HHS 1P50GM081883NIGMS NIH HHS P50 GM081883
6 · The paper itself

Abstract

Precise control of cell proliferation is fundamental to tissue homeostasis and differentiation. Mammalian cells commit to proliferation at the restriction point (R-point). It has long been recognized that the R-point is tightly regulated by the Rb-E2F signaling pathway. Our recent work has further demonstrated that this regulation is mediated by a bistable switch mechanism. Nevertheless, the essential regulatory features in the Rb-E2F pathway that create this switching property have not been defined. Here we analyzed a library of gene circuits comprising all possible link combinations in a simplified Rb-E2F network. We identified a minimal circuit that is able to generate robust, resettable bistability. This minimal circuit contains a feed-forward loop coupled with a mutual-inhibition feedback loop, which forms an AND-gate control of the E2F activation. Underscoring its importance, experimental disruption of this circuit abolishes maintenance of the activated E2F state, supporting its importance for the bistability of the Rb-E2F system. Our findings suggested basic design principles for the robust control of the bistable cell cycle entry at the R-point.

Indexed as

Feedback, PhysiologicalGene Regulatory NetworksAnimalsCell CycleCell Cycle ProteinsCell DifferentiationCell ProliferationE2F Transcription FactorsMammalsModels, BiologicalRetinoblastoma ProteinSignal TransductionCell Cycle ProteinsE2F Transcription FactorsRetinoblastoma Protein

Identifiers

PMID21525871
PMCPMC3101952

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.